Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Rouet

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
BMC Systems Biology|September 15, 2014
(13)C metabolic flux analysis shows that resistin impairs the metabolic response to insulin in L6E9 myotubesShirley Guzmán, Silvia Marin, Anibal Miranda, et al.
Plos One|July 7, 2011
Blood signature of pre-heart failure: a microarrays studyFatima Smih, Franck Desmoulin, Matthieu Berry, et al.
International Journal of Cardiology|October 13, 2018
Insulin like growth factor binding protein 2 (IGFBP-2) for risk prediction in patients with severe aortic stenosis undergoing Transcatheter Aortic Valve Implantation (TAVI)Johanna Maria Muessig, Michael Lichtenauer, Bernhard Wernly, et al.
Medicine|November 19, 2016
Increased mean aliphatic lipid chain length in left ventricular hypertrophy secondary to arterial hypertension: A cross-sectional studyMaria Francesca Evaristi, Céline Caubère, Romain Harmancey, et al.
International Journal of Cardiology|December 7, 2019
Insulin-like Growth Factor Binding Protein 2 predicts mortality risk in heart failureManon Barutaut, Pauline Fournier, William F Peacock, et al.
Journal of Biomedical Research|October 22, 2014
Heart 'omics' in AGEing (HOMAGE): design, research objectives and characteristics of the common databaseLotte Jacobs, Lutgarde Thijs, Yu Jin, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 6, 2021
Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trialJoão Pedro Ferreira, Timothy Collier, Andrew L Clark, et al.
JACC. Heart Failure|February 7, 2021
Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HFJoão Pedro Ferreira, Job Verdonschot, Ping Wang, et al.
European Heart Journal|November 20, 2020
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trialJohn G F Cleland, João Pedro Ferreira, Beatrice Mariottoni, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
BMC Systems Biology|September 15, 2014
(13)C metabolic flux analysis shows that resistin impairs the metabolic response to insulin in L6E9 myotubesShirley Guzmán, Silvia Marin, Anibal Miranda, et al.
Plos One|July 7, 2011
Blood signature of pre-heart failure: a microarrays studyFatima Smih, Franck Desmoulin, Matthieu Berry, et al.
International Journal of Cardiology|October 13, 2018
Insulin like growth factor binding protein 2 (IGFBP-2) for risk prediction in patients with severe aortic stenosis undergoing Transcatheter Aortic Valve Implantation (TAVI)Johanna Maria Muessig, Michael Lichtenauer, Bernhard Wernly, et al.
Medicine|November 19, 2016
Increased mean aliphatic lipid chain length in left ventricular hypertrophy secondary to arterial hypertension: A cross-sectional studyMaria Francesca Evaristi, Céline Caubère, Romain Harmancey, et al.
International Journal of Cardiology|December 7, 2019
Insulin-like Growth Factor Binding Protein 2 predicts mortality risk in heart failureManon Barutaut, Pauline Fournier, William F Peacock, et al.
Journal of Biomedical Research|October 22, 2014
Heart 'omics' in AGEing (HOMAGE): design, research objectives and characteristics of the common databaseLotte Jacobs, Lutgarde Thijs, Yu Jin, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 6, 2021
Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trialJoão Pedro Ferreira, Timothy Collier, Andrew L Clark, et al.
JACC. Heart Failure|February 7, 2021
Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HFJoão Pedro Ferreira, Job Verdonschot, Ping Wang, et al.
European Heart Journal|November 20, 2020
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trialJohn G F Cleland, João Pedro Ferreira, Beatrice Mariottoni, et al.
Pageof 3